Related Experiment Video
Updated: Feb 10, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Contemporary approach to stroke prevention in atrial fibrillation: Risks, benefits, and new options
Jonathan Stock1, Brian J Malm2
1Yale University, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.
Insights
Atrial fibrillation increases stroke risk five-fold. Managing this risk involves accurate assessment and therapies like anticoagulation or mechanical interventions.
Area of Science:
- Cardiology
- Neurology
- Public Health
Background:
- Atrial fibrillation affects millions, significantly increasing stroke risk.
- Stroke is a primary driver of morbidity and mortality in atrial fibrillation patients.
- This condition poses a greater stroke risk than hypertension, coronary disease, or heart failure.
Purpose of the Study:
- To review current stroke risk stratification in atrial fibrillation.
- To discuss the mechanisms, risks, and benefits of existing and emerging therapies.
- To provide an overview of managing thromboembolic complications in atrial fibrillation.
Main Methods:
- Literature review of current guidelines and research.
- Analysis of stroke risk factors and stratification tools.
- Evaluation of pharmacologic and non-pharmacologic interventions.
Main Results:
- Atrial fibrillation is a major independent risk factor for stroke.
- Anticoagulation, including direct oral anticoagulants, is the standard of care.
- Mechanical interventions are increasingly used for stroke risk reduction in select patients.
Conclusions:
- Accurate stroke risk assessment is crucial for atrial fibrillation management.
- A combination of pharmacologic and non-pharmacologic approaches optimizes stroke prevention.
- Understanding evolving therapies is key to improving patient outcomes.
Abstract:
Atrial fibrillation is a common diagnosis affecting nearly 3 million adults in the United States. Morbidity and mortality in these patients is driven largely by the associated increased risk of thromboembolic complications, especially stroke. Atrial fibrillation is a stronger risk factor than hypertension, coronary disease, or heart failure and is associated with an approximately five-fold increased risk. Mitigating stroke risk can be challenging and requires accurate assessment of stroke risk factors and careful selection of appropriate therapy. Anticoagulation, including the more recently introduced direct oral anticoagulants, is the standard of care for most patients. In addition, emerging non-pharmacologic mechanical interventions are playing an expanding role in reducing stroke risk in select patients. In this review we highlight the current approach to stroke risk stratification in atrial fibrillation and discuss in detail the mechanism, risks, and benefits of current and evolving therapies.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
03:03Amyloid Fibrils
01:29Contemporary Psychology
Biopsychology
Biopsychology, also known as biological psychology or behavioral neuroscience, focuses on the biological underpinnings of behavior and mental processes. It...
01:25Benefits of Self-Esteem
01:11Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
01:12Relative Risk